Fetal alcohol spectrum disorder: neurodevelopmentally and behaviorally indistinguishable from other neurodevelopmental disorders.
Attention
/ physiology
Canada
Child
Child Development
/ physiology
Child, Preschool
Female
Fetal Alcohol Spectrum Disorders
/ diagnosis
Humans
Male
Motor Activity
/ physiology
Neurodevelopmental Disorders
/ diagnosis
Predictive Value of Tests
Sensitivity and Specificity
Verbal Learning
/ physiology
Visual Perception
/ physiology
Classification function
Fetal alcohol spectrum disorder
Neurodevelopmental profile
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
28 10 2019
28 10 2019
Historique:
received:
29
05
2019
accepted:
12
09
2019
entrez:
30
10
2019
pubmed:
30
10
2019
medline:
12
5
2020
Statut:
epublish
Résumé
The lack of universally accepted diagnostic criteria and the high rate of psychiatric comorbidity make it difficult to diagnose Fetal Alcohol Spectrum Disorder (FASD). In an effort to improve the diagnosis of FASD, the current study aimed to identify a neurodevelopmental profile that is both sensitive and specific to FASD. A secondary analysis was conducted on data obtained from the Canadian component of the World Health Organization International Study on the Prevalence of FASD. Data on neurodevelopmental status and behavior were derived from a battery of standardized tests and the Child Behavior Checklist for 21 children with FASD, 28 children with other neurodevelopmental disorders, and 37 typically developing control children, aged 7 to 11 years. Two latent profile analyses were performed to derive discriminative profiles: i) children with FASD compared with typically developing control children, and ii) children with FASD compared with typically developing control children and children with other neurodevelopmental disorders. The classification function of the resulting profiles was evaluated using the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Confidence intervals (CIs) were approximated using 10,000 bootstrapped samples. The neurodevelopmental profile of FASD tested consisted of impairments in perceptual reasoning, verbal comprehension, visual-motor speed and motor coordination, processing speed (nonverbal information), attention and executive function, visuospatial processing, and language, in combination with rule-breaking behavior and attention problems. When children with FASD were compared with typically developing control children, a 2-class model fit the data best and resulted in a sensitivity of 95.2% (95% CI: 84.2-100.0%), specificity of 89.2% (95% CI: 78.4-97.5%), PPV of 83.3% (95% CI: 66.7-96.2%), and NPV of 97.1% (95% CI: 90.3-100.0%). When children with FASD were compared with typically developing control children and children with other neurodevelopmental disorders, the neurodevelopmental profile correctly identified only 56.9% (95% CI: 45.1-69.2%) of typically developing children and children with other neurodevelopmental disorders as not having FASD, and thus the profile was found not to be specific to children with FASD. The findings question the uniqueness of children with FASD with respect to their neurodevelopmental impairments and behavioral manifestations.
Sections du résumé
BACKGROUND
The lack of universally accepted diagnostic criteria and the high rate of psychiatric comorbidity make it difficult to diagnose Fetal Alcohol Spectrum Disorder (FASD). In an effort to improve the diagnosis of FASD, the current study aimed to identify a neurodevelopmental profile that is both sensitive and specific to FASD.
METHODS
A secondary analysis was conducted on data obtained from the Canadian component of the World Health Organization International Study on the Prevalence of FASD. Data on neurodevelopmental status and behavior were derived from a battery of standardized tests and the Child Behavior Checklist for 21 children with FASD, 28 children with other neurodevelopmental disorders, and 37 typically developing control children, aged 7 to 11 years. Two latent profile analyses were performed to derive discriminative profiles: i) children with FASD compared with typically developing control children, and ii) children with FASD compared with typically developing control children and children with other neurodevelopmental disorders. The classification function of the resulting profiles was evaluated using the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Confidence intervals (CIs) were approximated using 10,000 bootstrapped samples.
RESULTS
The neurodevelopmental profile of FASD tested consisted of impairments in perceptual reasoning, verbal comprehension, visual-motor speed and motor coordination, processing speed (nonverbal information), attention and executive function, visuospatial processing, and language, in combination with rule-breaking behavior and attention problems. When children with FASD were compared with typically developing control children, a 2-class model fit the data best and resulted in a sensitivity of 95.2% (95% CI: 84.2-100.0%), specificity of 89.2% (95% CI: 78.4-97.5%), PPV of 83.3% (95% CI: 66.7-96.2%), and NPV of 97.1% (95% CI: 90.3-100.0%). When children with FASD were compared with typically developing control children and children with other neurodevelopmental disorders, the neurodevelopmental profile correctly identified only 56.9% (95% CI: 45.1-69.2%) of typically developing children and children with other neurodevelopmental disorders as not having FASD, and thus the profile was found not to be specific to children with FASD.
CONCLUSION
The findings question the uniqueness of children with FASD with respect to their neurodevelopmental impairments and behavioral manifestations.
Identifiants
pubmed: 31660907
doi: 10.1186/s12888-019-2289-y
pii: 10.1186/s12888-019-2289-y
pmc: PMC6816158
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
322Références
J Int Neuropsychol Soc. 2011 May;17(3):463-73
pubmed: 21349236
Can J Psychiatry. 2015 Dec;60(12):587-90
pubmed: 26720828
Neuropsychol Rev. 2011 Jun;21(2):81-101
pubmed: 21503685
Biochem Cell Biol. 2018 Apr;96(2):241-251
pubmed: 28521112
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
Genome Med. 2017 Nov 30;9(1):106
pubmed: 29191242
Pediatrics. 2015 Feb;135(2):264-70
pubmed: 25583914
Pediatrics. 2016 Aug;138(2):
pubmed: 27464676
Curr Top Med Chem. 2017;17(7):808-828
pubmed: 27086780
Child Neuropsychol. 2013;19(6):579-87
pubmed: 23030694
Lancet. 2016 Mar 5;387(10022):978-987
pubmed: 26777270
CMAJ. 2016 Feb 16;188(3):191-197
pubmed: 26668194
Alcohol Clin Exp Res. 2013 Mar;37(3):517-28
pubmed: 22974253
Alcohol Res Health. 2001;25(3):159-67
pubmed: 11810953
CMAJ. 2005 Mar 1;172(5 Suppl):S1-S21
pubmed: 15738468
Appl Neuropsychol Adult. 2017 May-Jun;24(3):288-293
pubmed: 27101084
Child Psychiatry Hum Dev. 2016 Apr;47(2):335-46
pubmed: 26202432
BMC Public Health. 2019 Jun 28;19(1):845
pubmed: 31253131
J Pediatr. 1997 Nov;131(5):718-21
pubmed: 9403652
Front Psychol. 2014 Aug 21;5:920
pubmed: 25191298
Dev Disabil Res Rev. 2009;15(3):218-24
pubmed: 19731385